The FDA approved immediate emergency use authorization for Johnson & Johnson’s vaccine for COVID-19. While this is the third vaccine to combat the novel virus first documented in late 2019, it does differ than its counterparts by Moderna and Pfizer/BioNtech in several ways: it only requires 1 dose, it has a different efficacy, it provides quicker protection, it is easier to handle and store, and it is made using a different technology. Click the link below to read more!
https://www.cnn.com/2021/02/27/health/johnson-johnson-coronavirus-vaccine-explainer/index.html
Southwest Virginia Graduate Medical Education Consortium 